Theralase Technologies Stock Probability of Future Stock Price Finishing Over 0.26
| TLT Stock | CAD 0.26 0.01 3.70% |
Theralase |
Theralase Technologies Target Price Odds to finish over 0.26
The tendency of Theralase Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.26 | 90 days | 0.26 | about 35.83 |
Based on a normal probability distribution, the odds of Theralase Technologies to move above the current price in 90 days from now is about 35.83 (This Theralase Technologies probability density function shows the probability of Theralase Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Theralase Technologies has a beta of 0.96. This usually implies Theralase Technologies market returns are correlated to returns on the market. As the market goes up or down, Theralase Technologies is expected to follow. Moreover Theralase Technologies has an alpha of 1.2628, implying that it can generate a 1.26 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Theralase Technologies Price Density |
| Price |
Predictive Modules for Theralase Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Theralase Technologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Theralase Technologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Theralase Technologies is not an exception. The market had few large corrections towards the Theralase Technologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Theralase Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Theralase Technologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.26 | |
β | Beta against Dow Jones | 0.96 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | 0.09 |
Theralase Technologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Theralase Technologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Theralase Technologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Theralase Technologies is way too risky over 90 days horizon | |
| Theralase Technologies has some characteristics of a very speculative penny stock | |
| Theralase Technologies appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.07 M. Net Loss for the year was (4.57 M) with profit before overhead, payroll, taxes, and interest of 628.17 K. | |
| Theralase Technologies has accumulated about 1.67 M in cash with (4.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from news.google.com: Theralase Expands Cancer Study with Promising Results - MSN |
Theralase Technologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Theralase Stock often depends not only on the future outlook of the current and potential Theralase Technologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Theralase Technologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 220 M | |
| Cash And Short Term Investments | 43.9 K |
Theralase Technologies Technical Analysis
Theralase Technologies' future price can be derived by breaking down and analyzing its technical indicators over time. Theralase Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Theralase Technologies. In general, you should focus on analyzing Theralase Stock price patterns and their correlations with different microeconomic environments and drivers.
Theralase Technologies Predictive Forecast Models
Theralase Technologies' time-series forecasting models is one of many Theralase Technologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Theralase Technologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Theralase Technologies
Checking the ongoing alerts about Theralase Technologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Theralase Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Theralase Technologies is way too risky over 90 days horizon | |
| Theralase Technologies has some characteristics of a very speculative penny stock | |
| Theralase Technologies appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 1.07 M. Net Loss for the year was (4.57 M) with profit before overhead, payroll, taxes, and interest of 628.17 K. | |
| Theralase Technologies has accumulated about 1.67 M in cash with (4.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from news.google.com: Theralase Expands Cancer Study with Promising Results - MSN |
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.